IL-6 is involved in various oncogenic activities (cell proliferation, cell survival, migration, invasiveness and resistance towards anticancer therapy), therefore making IL-6 signaling cascades in breast cancer a target of choice. This evidence concerns the gene IL6 and breast cancer.